[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623714":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":30,"responsibleParty":45,"collaborators":19,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":19,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":19,"studyType":60,"phases":61,"briefSummary":64,"conditions":65,"keywords":19,"overallStatus":32,"whyStopped":19,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Peking Union Medical College Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Al18F-NOTA-FAPI PET\u002FCT(PET\u002FMRI)","EXPERIMENTAL","Evaluation of dosimetry, safety, diagnostic accuracy, and clinical treatment strategy guidance ability of Al18F-NOTA-FAPI PET\u002FCT(or PET\u002FMRI) in patients with malignant tumor,cardiovascular or immune disease.",[13],"Other: Al18F-NOTA-FAPI PET\u002FCT(or PET\u002FMRI)",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Al18F-NOTA-FAPI PET\u002FCT(or PET\u002FMRI)","Participants will receive an intravenous injection of Al18F-NOTA-FAPI, prepared on-site and measured by qualified personnel using a dose calibrator, with readings and time recorded. The radiopharmaceutical will be slowly administered through a three-way stopcock, followed by a flush with 5 mL of normal saline. The recommended dose is approximately 4.81 MBq\u002Fkg (0.13 mCi\u002Fkg) body weight, with variations depending on drug yield and clinical scheduling. PET\u002FCT(or PET\u002FMRI) imaging are planned 45-90 minutes after administration, with adjustments based on drug yield and equipment availability.",[9],null,[21,26],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Li Huo, MD","CONTACT","+86 18612672038","huoli@pumch.cn",{"name":27,"role":23,"phone":28,"phoneExt":19,"email":29},"Xueqian Yang, MS","+86 18801349606","yangxq202508@163.com",[31],{"facility":5,"status":32,"city":33,"state":19,"zip":19,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"RECRUITING","Beijing","China","CN",{"type":37,"coordinates":38},"Point",[39,40],116.39723,39.9075,{"lat":40,"lon":39},[43],{"name":5,"role":23,"phone":44,"phoneExt":19,"email":25},"+86 010-69154702",{"type":46,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100623714","phase-1-clinical-application-of-al18f-nota-fapi-04-petct-or-petmri-imaging-in-malignant-tumorcardiovascular-or-immune-disease-100623714",false,"NCT07400224","Clinical Application of Al18F-NOTA-FAPI-04 PET\u002FCT or PET\u002FMRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease","Inclusion Criteria:\n\n* a. Age 18 years old or above, gender not restricted. b. Have undergone a health check-up within the last 3 months (at least completed chest X-ray \u002F chest CT and abdominal B-ultrasound and other examinations), and no major diseases were found.\n\nExclusion Criteria:\n\n* As this study involves certain radiation exposure, patients who have had frequent radiation exposure due to clinical needs (those who have undergone a CT or PET\u002FCT examination once within 3 months or 1 month respectively) are not included in the study.",true,"ALL","18 Years","88 Years",{"count":58,"type":59},600,"ESTIMATED","INTERVENTIONAL",[62,63],"PHASE1","PHASE2","This prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-FAPI PET imaging in patients with malignant tumor,cardiovascular or immune disease. And evaluates the potential of Al18F-NOTA-FAPI PET imaging in Clinical treatment strategy guidance.",[66,67,68],"Hyperthyroidism, Autoimmune","Cardiovascular Abnormalities","Malignant Tumor","2026-02-03",{"date":71,"type":72},"2026-02-10","ACTUAL",{"date":74,"type":72},"2022-05-10",{"date":76,"type":59},"2028-12-31",{"name":5,"class":6},1]